Report Highlights
The global bioanalytical testing services market reached $2.9 billion in 2022, should reach $3.2 billion by 2023 and $6.6 billion by 2028 with a compound annual growth rate (CAGR) of 15.2% during the forecast period of 2023-2028.
Report Includes
- 45 data tables and 44 additional tables
- An overview of the global market for bioanalytical testing services
- An estimate of market size and analyses of global market trends, with data from 2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Characterization and quantification of the global market for bioanalytical testing services on the basis of technology, application, end user and region
- Information on sample requirements for discovery bioanalysis, preclinical and clinical bioanalysis and descriptions of toxicokinetic and pharmacokinetics studies
- Coverage of technological advances in the drug discovery process and information on investments in the R&D of biologics, biosimilars and other specialty drugs
- An examination of the drivers and constraints that will shape the market, and a discussion of the upcoming market opportunities in order to forecast the market by its segments and sub-segments
- An assessment of existing products as well as those in the pipelines of the major players in the market
- Coverage of recent advances, emerging technologies and ongoing developments in the industry
- An evaluation of key industry acquisitions and strategic alliances, and an analysis of the market shares of the leading companies
- Company profiles of major players within the industry, including SGS S.A., Intertek Group PLC, Eurofins Scientific SE, Charles River International Laboratories, Inc., Inotiv Inc., and WuXi AppTec
Report Scope
The report’s scope includes an overview of the global market on bioanalytical testing services and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.
The report analyzes leading services, applications, end user, and product details for the bioanalytical testing services market. Leading market players’ profiles, specific services, financial information, and recent market activities are provided. This report also assesses companies’ mergers & acquisitions and funding activities and their impact in the face of the competitive environment. The report details the bioanalytical testing services market based on service type, application, and end user. The market is segmented into pharmacokinetics studies, bioequivalence and bioavailability studies, biomarker testing services, cell-based assays, virology testing, method development, optimization & validation, serology, immunogenicity, and neutralizing antibodies, and others.
The market is categorized as oncology, immunology, neurology, infectious diseases, cardiovascular diseases, and others. The market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, contract development and manufacturing organizations, and others. The report also consists of the impact of the COVID-19 pandemic on this market. Regional analysis includes North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the World (South America, and the Middle East and Africa).
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||||||||
| Forecast period considered | 2023-2028 | ||||||||||||||||
| Base year market size | $2.9 billion | ||||||||||||||||
| Market size forecast | $6.6 billion | ||||||||||||||||
| Growth rate | CAGR of 15.2% for the forecast period of 2023-2028 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Service Type, Application, End User | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (RoW) | ||||||||||||||||
| Countries covered | U.S., Mexico, Canada, France, Germany, UK, Italy, Spain, Rest of Europe, China, India, Japan, Rest of APAC, Middle East, Africa, South America | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Oncology Biomarkers: Global Markets
The global oncology biomarkers market reached $15.5 billion in 2022, should reach $17.6 billion by 2023 and $35.2 billion by 2028 with a compound annual growth rate (CAGR) of 14.9% during the forecast period of 2023-2028.
Biologics Development and Manufacturing Testing: Technologies and Global Markets
The global market for biologics safety testing is estimated to increase from $7.4 billion in 2022 to reach $18.2 billion by 2027, at a compound annual growth rate (CAGR) of 19.9% from 2022 through 2027.
Global Oncology Pharmaceuticals Market
The global market for oncology pharmaceuticals should grow from $177.4 billion in 2021 to $313.7 billion by 2026, at compound annual growth rate (CAGR) of 12.1% for the period of 2021-2026.
Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging
The global market for contract pharmaceutical manufacturing, research and packaging services should grow from $168.0 billion in 2021 to $214.7 billion by 2026, at a compound annual growth rate (CAGR) of 5.0% during the forecast period of 2021-2026.
Recent Reports
Companion Diagnostics: Technologies and Markets
The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Non-Fungible Tokens (NFT): Global Market
The global NFTs market should reach $37.6 billion by 2022 and $125.6 billion by 2027, with a compound annual growth rate (CAGR) of 27.3% during the forecast period of 2022-2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More